Newsletter Subject

Fetus Removed From Brain of 1-Year-Old Girl

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Sat, Mar 11, 2023 12:18 PM

Email Preheader Text

Weekly Review Saturday, March 11, 2023 THE BREAK ROOM CME SPOTLIGHT WORDOSIS ADVERTISEMENT CME SPOTL

[MEDPAGE TODAY]( Weekly Review Saturday, March 11, 2023 [Fetus Removed From Brain of 1-Year-Old Girl]( [Autopsies Show Relationship Between Alzheimer's Pathology and Diet in Older Adults]( [Ex-TV Doc Sentenced for Asking Child for Nude Pics; Women Denied Abortions Sue Texas]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Optimizing Outcomes in Gastroesophageal Cancers: Expert Insights on Novel Biomarkers and Therapies]( [Statin Users Show LDL Doesn't Come Close to Telling Whole Story of ASCVD]( [Early Metformin Cuts Long COVID Risk]( WORDOSIS [Play Today's Wordosis: Our Medical Word Game]( ADVERTISEMENT [Tough to Swallow: Clinicians Are Neglecting Alcohol Use]( CME SPOTLIGHT [Differentiating Novel Classes of Immunotherapy for Advanced Melanoma]( [Are Physicians With MBAs Traitors to Healthcare?]( [Cases of Breast Implant-Associated Lymphoma Continue to Accumulate]( [After Severe COVID, Cognitive Trajectories Go One of Three Ways]( CME SPOTLIGHT [Immunotherapy in Advanced Melanoma: Evidence-Based Adverse Event Management Strategies to Improve Patient Outcomes]( [Amid Relaxing COVID Rules for Health Workers, San Francisco Is Reinforcing Them]( [Doctors at Florida Hospital Sent Death Threats Over COVID Policies]( [Incident Cognitive Impairment Tied to Stress]( CME SPOTLIGHT [Expert Perspectives in Managing Lower-Risk Myelodysplastic Syndromes]( [FDA Mandate on Acetaminophen-Opioid Combinations Appeared Effective]( [Troponin-Sensing Wearable; Keto Diet's Heart Risk; COAPT at 5 Years]( [Antibody-Drug Conjugates Take Breast Cancer Field by Storm]( CME SPOTLIGHT [Incorporating Recent Data Into Current Treatment Paradigms in Melanoma]( ['It Verges on Malpractice': What We Heard This Week]( [When a Warm Handoff Is Not So Warm]( [Alcohol-Related Screening in Primary Care; Ablation for Hypertension]( CME SPOTLIGHT [Integrating New and Emerging Biomarkers and Targeted Therapies to Individualize Colorectal Cancer Care]( [Depressive Symptoms Linked to Higher Risk of Acute Stroke]( [Jimmy Carter's Melanoma; Post-Op Osimertinib Boosts OS; $83K for Unproven Therapy]( [Typical Chest CTs for COVID Less Common After Omicron, Vaccination]( CME SPOTLIGHT [Integrating the Latest Evidence into Patient-Centered Treatment for Advanced/Metastatic Triple Negative Breast Cancer]( [The Cost of Yet Another Pediatric Hospital Closure]( [Would You Refuse All Medical Interventions After Age 75?]( [AMA, Surgeon General Propose Ways to Prevent Doctor Burnout]( CME SPOTLIGHT [Individualizing von Willebrand Disease Treatment Strategies for Patients With Severe and Frequent Bleeds]( [Details Emerge on LSD-Fueled Final Days of Malibu Ophthalmologist]( [Immediate Complete Revascularization Non-Inferior to Staged Procedure]( [Biden Unveils Plan for Medicare Funding in $6.8 Trillion Budget Proposal]( [HIPAA Mistakes While Texting; AI and Human Touch in Healthcare]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_DHE_Weekly?xid=nl_mpt_DHE_2023-03-11&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

26/06/2024

Sent On

26/06/2024

Sent On

26/06/2024

Sent On

25/06/2024

Sent On

25/06/2024

Sent On

24/06/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.